Skip to main navigation
Maze Therapeutics logo
  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
  • Governance
    • governance overview
    • leadership & board
    • committees & compositions
  • SEC Filings
  • Stock Info
    • Stock Quote & Chart
    • Historic Price Lookup
    • Analyst Coverage
  • IR Resources
    • Investor FAQs
    • Email Alerts
    • Investor Contacts

Maze Therapeutics

SEC filing details

Document Details

Form
10-Q
Filing Date
August 11, 2026
Document Date
Jun 30, 2026
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Maze Therapeutics
Issuer
MAZE THERAPEUTICS, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
XML - XBRL INSTANCE DOCUMENT
Maze footer logo
We are committed to developing breakthrough precision medicines for common diseases with large unmet medical needs.
Further Together.
Impact Obsessed.
Stand True.
  • Privacy Notice
  • Terms of Use
  • Contact Us
  • X logo
  • LinkedIn logo